HomeRVMD • NASDAQ
add
Revolution Medicines Inc
Previous close
$40.74
Day range
$37.90 - $41.44
Year range
$29.00 - $62.40
Market cap
7.07B USD
Avg Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 28.21M | 51.33% |
Net income | -194.57M | -20.45% |
Net profit margin | — | — |
Earnings per share | -1.12 | 2.18% |
EBITDA | -214.61M | -40.11% |
Effective tax rate | 0.39% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.29B | 23.55% |
Total assets | 2.56B | 24.09% |
Total liabilities | 293.10M | 24.45% |
Total equity | 2.27B | — |
Shares outstanding | 185.91M | — |
Price to book | 3.34 | — |
Return on assets | -25.03% | — |
Return on capital | -26.68% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -194.57M | -20.45% |
Cash from operations | -138.29M | -14.70% |
Cash from investing | -392.90M | -3.29% |
Cash from financing | 873.80M | 4.10% |
Net change in cash | 342.61M | 1.25% |
Free cash flow | -70.69M | -142.66% |
About
Founded
2014
Headquarters
Website
Employees
534